FP.28 IGNITE DMD phase I/II study of SGT-001 microdystrophin gene therapy for DMD: Long-term outcomes and expression update
| Autor: | Dreghici, R. Donisa, Redican, S., Lawrence, J., Brown, K., Wang, F., Gonzalez, J., Schneider, J., Morris, C., Shieh, P., Byrne, B. |
|---|---|
| Zdroj: | In Neuromuscular Disorders October 2022 32 Supplement 1:S98-S98 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect